Article
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients
2023-02-02
Abstract excerpt
<h4>Background: </h4> Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of early diagnosis and accurate prognostic prediction. <h4>Methods: </h4>: Immune-related mRNAs (IRmRNAs) wer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9615fbce-0e2d-5a28-af2d-6eb38d794fa9
- DOI
- 10.21203/rs.3.rs-2520613/v1
